India’s First Indigenous H5N1 Bird Flu Vaccine to Be Launched on November 20
India's first indigenous H5N1 bird flu vaccine, developed by ICAR-NIHSAD in Bhopal, will be dedicated to the nation by Shivraj Singh Chouhan on November 20, marking a major step in poultry disease control.
Highly Pathogenic Avian Influenza (HPAI), commonly known as bird flu, is a serious disease that affects chickens and other birds. The disease can cause mortality rates of nearly 100 per cent among infected birds. India first detected the disease in 2006, and since then, more than 500 outbreaks involving the H5N1 and H5N8 subtypes have been recorded across the country.
Bird flu outbreaks pose a major economic threat to the poultry industry. Infected birds often have to be culled on a large scale, while trade restrictions may also be imposed to contain the spread of the disease. These measures affect poultry businesses and the livelihoods of farmers. According to available figures, bird flu outbreaks caused direct and indirect economic losses of approximately Rs 2,200 crore to Rs 3,000 crore in India in 2006. The disease also affects the prices of poultry products and international trade.
Until now, no specific commercial vaccine was available in India against H5N1 virus clade 2.3.2.1a, which has been circulating in the country. Addressing this challenge, the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), based in Bhopal, has developed the country's first indigenous H5N1 chicken vaccine.
The vaccine is designed to protect chickens against the H5N1 virus variant circulating in India. Its development is expected to help control bird flu outbreaks and reduce the economic losses suffered by the poultry sector.
The spread of H5N1 has also raised concerns beyond the poultry industry. In recent years, infections have been reported not only among birds but also in mammals and other animal species. Human infections have also been recorded. According to figures attributed to the World Health Organization (WHO), a total of 1,003 human cases of H5N1 avian influenza have been reported across 25 countries, including India, since 2003. Of these cases, 479 people have died.
The development of the indigenous vaccine is therefore significant not only for poultry farming but also from the perspective of animal and public health. By protecting chickens against infection, the vaccine is expected to strengthen efforts to prevent the spread of bird flu and minimise financial losses for poultry farmers.
Shivraj Singh Chouhan will dedicate the vaccine to the nation during an event in Bhopal on November 20. The development represents an important step towards strengthening India's ability to tackle animal diseases through indigenous technological solutions.

Comment List